The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...

Rachel Dalthorp, MD, discusses how zuranolone (Zurzuvae) can improve postpartum depression when compared with previous ...

This interview accompanies the third podcast in our National Recovery Month series with Kim MacDonald-Wilson, ScD, CPRP, ...

Joseph Alvarnas, MD, of City of Hope, recaps yesterday's Institute for Value-Based Medicine® (IVBM) event on value-based oncology care, emphasizing patient-centered approaches and how attendees can ...

Anant Madabhushi, PhD, executive director for the Emory Empathetic AI for Health Institute, discusses the potential of ...

Coverage from the Institute for Value-Based Medicine session at Ohio State University. This article will appear in the ...

Physicians in the US, Germany, and France show gaps in their knowledge of the treatment of of refractory/relapsed chronic ...

More than 25 million people lost their Medicaid coverage during the unwinding process conducted by all states after the ...

Findings from a new study reveal significant racial differences in skin biopsy frequency for psoriasis diagnosis, indicating ...

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...

The impact alopecia areata (AA) has on patients' health-related quality of life (HRQOL) may not be accurately measured with ...

Clinical decision-making can be difficult for patients with SMA due to the lack of clinical trials comparing treatment ...